-
States and health providers report they've dispensed less than half their supply from the government, raising fears that the drugs may go to waste while people who could benefit get sicker.
-
The White House asked for more money from Congress to keep its COVID response going. But that hasn't happened, so some things need to be wound down.
-
If you think you might have COVID-19 and are at high risk, you may be able to get tested at a clinic and treated with antiviral drugs right away, under the next phase of the pandemic plan.
-
Unlike other monoclonal antibody therapies, Evusheld is not meant to treat active coronavirus infection. Instead, it's preventative medicine for people with compromised immune systems.
-
The roughly 7 million Americans who are immunocompromised — including many people with disabilities — live with much higher risk of COVID-19, and near-constant vigilance.
-
So far the government has distributed nearly 400,000 doses of Evusheld, a new drug that protects against COVID-19. Some 7 million Americans could benefit from the drug right away.